These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21529433)

  • 1. Value of [18F] fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in diagnosis and localization of Cushing's disease.
    Xin C; Rui-xue C; Hui P; Tao Y; Hui-Juan Z; Fang L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Apr; 33(2):107-10. PubMed ID: 21529433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of fused positron emission tomography/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing's disease.
    Alzahrani AS; Farhat R; Al-Arifi A; Al-Kahtani N; Kanaan I; Abouzied M
    Pituitary; 2009; 12(4):309-14. PubMed ID: 19387839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome.
    Pacak K; Ilias I; Chen CC; Carrasquillo JA; Whatley M; Nieman LK
    J Clin Endocrinol Metab; 2004 May; 89(5):2214-21. PubMed ID: 15126544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome.
    Markou A; Manning P; Kaya B; Datta SN; Bomanji JB; Conway GS
    Eur J Endocrinol; 2005 Apr; 152(4):521-5. PubMed ID: 15817906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome.
    Koulouri O; Steuwe A; Gillett D; Hoole AC; Powlson AS; Donnelly NA; Burnet NG; Antoun NM; Cheow H; Mannion RJ; Pickard JD; Gurnell M
    Eur J Endocrinol; 2015 Oct; 173(4):M107-20. PubMed ID: 26245763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved diagnostic accuracy of inferior petrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing's disease.
    Booth GL; Redelmeier DA; Grosman H; Kovacs K; Smyth HS; Ezzat S
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2291-5. PubMed ID: 9661597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRH stimulation improves
    Boyle J; Patronas NJ; Smirniotopoulos J; Herscovitch P; Dieckman W; Millo C; Maric D; Chatain GP; Hayes CP; Benzo S; Scott G; Edwards N; Ray Chaudhury A; Lodish MB; Sharma S; Nieman LK; Stratakis CA; Lonser RR; Chittiboina P
    Endocrine; 2019 Jul; 65(1):155-165. PubMed ID: 31062234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing the accuracy of Inferior petrosal sinus sampling: validation of the use of Prolactin as a marker of pituitary venous effluent in the diagnosis of Cushing's disease.
    Grant P; Dworakowska D; Carroll P
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):555-9. PubMed ID: 22017348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone suppression for
    Kim K; Kim DK; Moon JH; Kim EH; Kim SH; Ku CR; Lee EJ
    Cancer Imaging; 2023 Sep; 23(1):85. PubMed ID: 37700359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain glucose metabolism is associated with hormone level in Cushing's disease: A voxel-based study using FDG-PET.
    Liu S; Wang Y; Xu K; Ping F; Wang R; Li F; Cheng X
    Neuroimage Clin; 2016; 12():415-9. PubMed ID: 27622138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferior petrosal sinus sampling in the diagnostic evaluation of Cushing's syndrome: K.E.M. experience.
    Kalgikar AM; Chandratreya SA; Goel A; Shrivastava M; Limaye US; Karvat A; Shah NS; Menon PS
    J Assoc Physicians India; 2005 Aug; 53():685-8. PubMed ID: 16398076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cavernous sinus sampling in selected cases of Cushing's disease.
    Flitsch J; Lüdecke DK; Knappe UJ; Grzyska U
    Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):329-35. PubMed ID: 12397531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary magnetic resonance imaging in Cushing's disease.
    Vitale G; Tortora F; Baldelli R; Cocchiara F; Paragliola RM; Sbardella E; Simeoli C; Caranci F; Pivonello R; Colao A;
    Endocrine; 2017 Mar; 55(3):691-696. PubMed ID: 27435590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing's syndrome.
    Lienhardt A; Grossman AB; Dacie JE; Evanson J; Huebner A; Afshar F; Plowman PN; Besser GM; Savage MO
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5711-4. PubMed ID: 11739426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin.
    Tamam MO; Mulazimoglu M; Guveli TK; Tamam C; Eker O; Ozpacaci T
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2120-30. PubMed ID: 23280029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of hCRH-stimulated (18) F-FDG PET-CT scan in localisation of pituitary microadenoma in Cushing's disease.
    Patt HP; Lele V; Lila A; Bandgar T; Shah N
    J Med Imaging Radiat Oncol; 2014 Apr; 58(2):213. PubMed ID: 24690246
    [No Abstract]   [Full Text] [Related]  

  • 18. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW; Kehoe ME; Shaker JL; Raff H
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of bilateral inferior petrosal sinus sampling in the diagnosis and surgical treatment of the ACTH-dependent Cushing's syndrome: a comparison with other tests.
    Shi X; Sun Q; Bian L; Zhao W; Shen J; Wang W; Ning G
    Neuro Endocrinol Lett; 2011; 32(6):865-73. PubMed ID: 22286783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.